EDMONTON, Alberta, July 18 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that it has received an order for 1.0 million VScan rapid test kits from the Middle East. The purchase of these test kits is to be paid for by irrevocable Letter of Credit issued by a Western Bank. This order will generate in excess of $US 2.0 million in gross revenue over the next 8 months. It is anticipated that the Company will sell in excess of 3.0 million VScan test kits in the Middle East over the next 18 months, generating in excess of $US 6.0 million in gross revenues from that region. Once again the VScan test kits are being used as a result of its performance in regulatory testing showing accuracy, ease of use, sensitivity and the fact that they can be used in any situation without the need of medical facilities. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria, and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright